Ledger.Open graph →

SEC Form D · filed October 28, 2021

Protego Biopharma

Offering

$51.0M

Sold

$51.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SAN DIEGO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Richard Labaudiniere · Charleston, SCExec · Director Jeffrey Kelly · Charlotte, NCDirector Edward Hurwitz · Waltham, MADirector Shelley Chu · San Diego, CADirector Helen Kim · Boston, MADirector Richard Labaudiniere · Charleston, SCExec · Director Jeffrey Kelly · Chalfont, PA, PADirector Edward Hurwitz · Waltham, MADirector Shelley Chu · San Diego, CADirector Helen Kim · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗